tykhr
sign in
free sign up
Apellis Pharmaceuticals Inc
Biotechnology
Healthcare
APLS
128 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
23.48
52 week high
39.94
high
23.68
52 week low
0.00
low
23.16
growth
-28.67 %
previous Close
23.49
P/E ratio
market cap
2.90 B
div yield
0
usd
Jun 2025
qoq
revenue
171 M
2.75 %
net incoming
-42.15 M
54.30 %
eps
0.00 %
55.41 %
eps surprise
31.25 %
net profit margin
-24.59 %
30.00 %
operating incoming
-40.39 M
51.53 %
net change in cash
11.64 M
122.05 %
cash on hand
370 M
3.25 %
cost of revenue
13.63 M
-60.34 %
top